China Medical System Lim... (CHSYF)

PNK: CHSYF · Real-Time Price · USD

0.93

-0.00 (-0.08%)

At close: May 01, 2025, 8:00 PM

China Medical System Income Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Revenue	7.01B	8.01B	9.31B	9.15B	8.94B	8.34B	7.68B	6.95B	6.22B	6.07B	5.74B	5.43B	5.32B	5.35B	5.41B	4.9B	4.05B
Cost of Revenue	1.85B	1.94B	2.11B	2.11B	2.13B	2.09B	1.97B	1.81B	1.6B	1.53B	1.49B	1.52B	1.62B	1.87B	2.11B	1.99B	1.7B
Gross Profit	5.17B	6.08B	7.21B	7.04B	6.81B	6.25B	5.71B	5.13B	4.62B	4.55B	4.25B	3.92B	3.7B	3.48B	3.3B	2.91B	2.36B
Operating Income	1.67B	2.71B	3.6B	3.55B	3.34B	3.15B	3.06B	2.76B	2.47B	2.36B	2.18B	2B	1.96B	1.87B	1.78B	1.52B	1.23B
Interest Income	87.18M	130.84M	66.47M	62.18M	81.69M	65.27M	80.99M	58.02M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	1.73B	2.87B	3.99B	3.76B	3.7B	3.46B	3.16B	2.82B	2.66B	2.49B	2.26B	2.01B	2B	1.81B	1.66B	1.5B	1.23B
Net Income	1.39B	2.4B	3.38B	3.26B	3.19B	3.02B	2.88B	2.53B	2.07B	1.96B	2.06B	1.85B	1.83B	1.67B	1.53B	1.38B	1.15B
Selling & General & Admin	3.27B	3.17B	3.46B	3.36B	3.34B	2.98B	2.58B	2.3B	2.09B	2.15B	2.06B	1.92B	1.74B	1.6B	1.53B	1.4B	1.12B
Research & Development	224.97M	195.13M	145.62M	125.43M	133.46M	114.76M	73.02M	66.52M	59.97M	45.05M	15.44M	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	3.5B	3B	3.28B	3.33B	3.18B	2.84B	2.62B	2.35B	1.95B	2.04B	1.98B	1.86B	1.63B	1.61B	1.61B	1.39B	1.11B
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	15.34M	18.06M	14.26M	11.54M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	1.87B	2.51B	2.78B	2.72B	2.78B	2.54B	2.27B	2.05B	1.88B	1.94B	1.82B	1.67B	1.52B	1.38B	1.31B	1.17B	921.93M
Cost & Expenses	5.34B	4.93B	5.39B	5.44B	5.31B	4.93B	4.58B	4.16B	3.54B	3.57B	3.47B	3.38B	3.24B	3.48B	3.72B	3.38B	2.81B
Income Tax Expense	355.63M	489.34M	593.91M	486.65M	506.09M	431.32M	278.13M	260.39M	567.86M	532M	202.82M	161.78M	175.72M	138.49M	131.06M	122.52M	72.83M
Shares Outstanding (Basic)	2.44B	2.45B	2.45B	2.45B	2.46B	2.46B	2.47B	2.47B	2.47B	2.48B	2.48B	2.49B	2.49B	2.49B	2.49B	2.49B	2.49B
Shares Outstanding (Diluted)	2.44B	2.45B	2.45B	2.45B	2.46B	2.46B	2.47B	2.47B	2.47B	2.48B	2.48B	2.49B	2.49B	2.49B	2.49B	2.49B	2.49B
EPS (Basic)	0.57	0.98	1.38	1.34	1.30	1.22	1.16	1.02	0.84	0.80	0.84	0.74	0.72	0.66	0.62	0.56	0.46
EPS (Diluted)	0.57	0.98	1.38	1.34	1.30	1.22	1.16	1.02	0.84	0.80	0.84	0.74	0.72	0.66	0.62	0.56	0.46
EBITDA	1.89B	2.92B	3.81B	3.76B	3.55B	3.36B	3.26B	2.96B	2.67B	2.55B	2.37B	2.2B	2.16B	2.07B	1.97B	1.69B	1.36B
EBIT	1.67B	2.71B	3.6B	3.55B	3.34B	3.15B	3.06B	2.76B	2.47B	2.36B	2.18B	2B	1.96B	1.87B	1.78B	1.52B	1.23B
Depreciation & Amortization	219.82M	209.3M	208.13M	209.08M	206.11M	206.05M	201.71M	197.06M	195.81M	194.5M	198.78M	198.99M	197.99M	196.42M	195.78M	175.86M	120.55M